ELFN1 and gastric cancer: ELFN1-AS1 inhibits TAOK1-mediated STK3 phosphorylation by binding to the PK domain of TAOK1, further inhibiting the kinase phosphorylation cascade and suppressing the Hippo signaling pathway to promote GC progression.